Brugts JJ, Radhoe SP, Clephas PRD, et al; MONITOR-HF investigators. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial. Lancet. 2023;401(10394):2113-2123. https://doi.org/10.1016/S0140-6736(23)00923-6 PMID:37220768

Abraham WT, Adamson PB, Bourge RC, et al; CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377(9766):658-666. https://doi.org/10.1016/S0140-6736(11)60101-3 PMID:21315441

Messori A, Romeo MR, Trippoli S. Remote monitoring in heart failure: inclusion of too many different studies in the same meta-analysis (Letter). JACC, 2024, in press. DOI 10.1016/j.jacc.2024.02.058

Cowie MR, Simon M, Klein L, Thokala P. The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective. Eur J Heart Fail. 2017;19(5):661-669. PMID:28176424 https://doi.org/10.1002/ejhf.747 PMID:28176424

Cowie MR, Thokala P, Ihara Z, Adamson PB, Angermann C. Real-time pulmonary artery pressure monitoring in heart failure patients: an updated cost-effectiveness analysis. ESC Heart Fail. 2023;10(5):3046-3054. PMID:37591524 https://doi.org/10.1002/ehf2.14496 PMID:37591524

Regione Toscana. Delibera N.947 del 27 Settembre 2016, Allegato 3, Tabella A, pag.4 (DRG 127, €3052). https://www.regione.toscana.it/bancadati/atti/Contenuto.xml?id=5127223&nomeFile=Delibera_n.947_del_27-09-2016-Allegato-3. Accessed December 2023.

Pradelli L, Iannazzo S, Zaniolo O. The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic Markov model. Am J Cardiovasc Drugs. 2009;9(6):383-392. PMID:19929036 https://doi.org/10.2165/11315730-000000000-00000 PMID:19929036